Implementation and community involvement in DOTS strategy: A systematic review of studies in China

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 11, 2012, Pages 1433-1440

  Hou, W L ^a   Song, F J ^b   Zhang, N X ^a   Dong, X X ^a   Cao, S Y ^a   Yin, X X ^a   Liu, Junan ^a   Lu, Zuxun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Community health personnel; Meta analysis; Tuberculosis patients

Indexed keywords

TUBERCULOSTATIC AGENT;

CASE MANAGEMENT; CHINA; CLINICAL EFFECTIVENESS; CLINICAL OBSERVATION; COMMUNITY CARE; COMMUNITY PROGRAM; DRUG SELF ADMINISTRATION; HEALTH AUXILIARY; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; INTERVENTION STUDY; META ANALYSIS; NURSE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT COURSE THERAPY; STAFF TRAINING; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL; URBAN RURAL DIFFERENCE; VOLUNTARY WORKER;

ANTITUBERCULAR AGENTS; CHINA; COMMUNITY HEALTH SERVICES; DIRECTLY OBSERVED THERAPY; DRUG RESISTANCE, BACTERIAL; HUMANS; MEDICATION ADHERENCE; QUALITY ASSURANCE, HEALTH CARE; SELF ADMINISTRATION; TUBERCULOSIS;

EID: 84867198022     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0080     Document Type: Review

References (35)

1. World Health Organization. International statistical classification of diseases and related health problems. 10th revision (ICD-10). 2nd ed. Geneva, Switzerland: WHO, 2007.
2. Tiemersma E W, van der Werf M J, Borgdorff M W, et al. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV-negative patients: a systematic review. PLoS ONE 2011; 6: e17601.
3. Frieden T R, Sbarbaro J A. Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull World Health Organ 2007; 85: 407-409.
4. World Health Organization. Global tuberculosis control. WHO report 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO, 2011.
5. Chinese Centre for Disease Control. The operational guidelines for the tuberculosis control program in China. Beijing, China: Ministry of Health, 2002.
6. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2004. WHO/HTM/TB/2004.331. Geneva, Switzerland: WHO, 2004.
7. Wang L D. [Tuberculosis control in China and its prospect]. Zhonghua Jie He He Hu Xi Za Zhi 2006; 29: 505-506. [C hinese]
8. Xianyi C, Fengzeng Z, Hongjin D, et al. The DOTS strategy in China: results and lessons after 10 years. Bull World Health Organ 2002; 80: 430-436.
9. Wang L, Liu J, Chin D. Progress in tuberculosis control and the evolving public-health system in China. Lancet 2007; 369: 691-696.
10. Hu D, Liu X, Chen J, et al. Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan 2008; 23: 43-55.
11. Khan M A, Walley J D, Witter S N, et al. Tuberculosis patient adherence to direct observation: results of a social study in Pakistan. Health Policy Plan 2005; 20: 354-365. (Pubitemid 41567094)
12. Mohan C I, Bishai D, Cavalcante S, Chaisson R E. The cost-effectiveness of DOTS in urban Brazil. Int J Tuberc Lung Dis 2007; 11: 27-32. (Pubitemid 46101842)
13. Walley J, Khan M A, Newell J, et al. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001; 357: 664-669. (Pubitemid 32206424)
14. Kamolratanakul P, Sawert H, Lertmaharit S, et al. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Trans R Soc Trop Med Hyg 1999; 93: 552-557. (Pubitemid 29495849)
15. Maher D, van Gorkom J L C, Gondrie P C F M, Raviglione M. Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. Int J Tuberc Lung Dis 1999; 3: 762-768. (Pubitemid 29425944)
16. Stop TB Partnership / World Health Organization. The Global Plan to Stop TB, 2006-2015. Part III. WHO/HTM/STB/2006.35. Geneva, Switzerland: WHO, 2006.
17. Chinese Centres for Disease Control. Operational guidelines for the tuberculosis control program in China. Beijing, China: Ministry of Health, 2008.
18. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.0.2. Oxford, UK: Cochrane Collaboration, 2009.
19. Mendis S, Johnston S C, Fan W, et al. Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ 2009; 88: 412-419.
20. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
21. Chinese Ministry of Health. The results of the Fifth National Epidemiological Sampling Survey of Tuberculosis. Beijing, China: Ministry of Health, 2011. http://www.tb123.org/n-xxy.asp?n-id=399 Accessed August 2012.
22. Yang Y, Li X, Zhou F, et al. Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis. PLoS ONE 2011; 6: e20343.
23. National Technical Steering Group of the Epidemiological Sampling Survey for TB. Report on nationwide survey of the epidemiology of TB in 2000. J Chinese Anti-Tuberculosis Assoc 2004; 24: 65-108.
24. Sui G M, Zhang D M. The implementation of DOTS in TB control of China. Chinese Rural Health Service Manag 2009; 29: 428-430.
25. Zhou Z Y, Yang G X, Zhao H Y. The epidemiological survey report of tuberculosis in Changchun city in 2001. J Chinese Anti-T uberculosis Assoc 2003; 25: 363-367.
26. Tao W W. The treatment and management of smear-positive cases of Health Ministry V program in Shandong Province. J Chinese Prev Med 2004; 5: 97-99.
27. Wang L. The implementation of DOTS in TB control program counties of Henan Province. J Henan Prev Med 1999; 10: 201-202.
28. Volmink J, Matchaba P, Garner P. Directly observed therapy and treatment adherence. Lancet 2000; 355: 1345-1350. (Pubitemid 30199013)
29. World Health Organization. An expanded DOTS framework for effective TB control, 2002. WHO/CDS/TB/2002.297. Geneva, Switzerland: WHO, 2002.
30. Akkslip S, Rasmithat S, Maher D, Sawert H. Direct observation of tuberculosis treatment by supervised family members in Yasothorn Province, Thailand. Int J Tuberc Lung Dis 1999; 3: 1061-1065.
31. Balasubramanian V N, Oommen K, Samuel R. DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India. Int J Tuberc Lung Dis 2000; 4: 409-413. (Pubitemid 30256842)
32. Xu B, Dong H J, Zhao Q, et al. DOTS in China - removing barriers or moving barriers? Health Policy Plan 2006; 21: 365-372. (Pubitemid 44594423)
33. Maher D, Floyd K, Sharma B V, et al. Community contribution to TB care: practice and policy review of experience of community contribution to TB care and recommendations to national TB programs. Geneva, Switzerland: WHO, 2003.
34. Pungrassami P, Johnsen S P, Chongsuvivatwong V, et al. Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis 2002; 6: 389-395. (Pubitemid 34492162)
35. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2003; 1: CD003343.